| Bioengineering of AAV2 Capsid at Specific Serine, Threonine, or Lysine Residues Improves Its Transduction Efficiency in Vitro and in Vivo N Gabriel, S Hareendran, D Sen, RA Gadkari, G Sudha, R Selot, ... Human gene therapy methods 24 (2), 80-93, 2013 | 103 | 2013 |
| Targeted Modifications in Adeno-Associated Virus Serotype 8 Capsid Improves Its Hepatic Gene Transfer Efficiency In Vivo D Sen, RA Gadkari, G Sudha, N Gabriel, YS Kumar, R Selot, R Samuel, ... Human gene therapy methods 24 (2), 104-116, 2013 | 68 | 2013 |
| Identification of a Soluble NADPH Oxidoreductase (BmNOX) with Antiviral Activites in the Gut Juice of Bombyx mori R Selot, V Kumar, S Shukla, K Chandrakuntal, M Brahmaraju, SB Dandin, ... Bioscience, biotechnology, and biochemistry 71 (1), 200-205, 2007 | 68 | 2007 |
| Optimized AAV rh. 10 vectors that partially evade neutralizing antibodies during hepatic gene transfer R Selot, S Arumugam, B Mary, S Cheemadan, GR Jayandharan Frontiers in Pharmacology 8, 441, 2017 | 18 | 2017 |
| Nucleotide sequences, methods, kit and a recombinant cell thereof S Hareendran, N Gabriel, D Sen, R Gadkari, S Govindarajan, ... US Patent App. 13/886,241, 2014 | 18 | 2014 |
| Molecular characterization and expression analysis of BmNOX in two strains of Bombyx mori with contrasting viral resistance phenotype R Selot, V Kumar, SC Sekhar, PG Kumar Archives of Insect Biochemistry and Physiology: Published in Collaboration …, 2010 | 17 | 2010 |
| Nanoparticle coated viral vectors for gene therapy R Selot, S Marepally, P Kumar Vemula, G R Jayandharan Current Biotechnology 5 (1), 44-53, 2016 | 13 | 2016 |
| Recent developments in gene therapy research in India R Selot, A Ghosh Journal of Biosciences 49 (1), 37, 2024 | 1 | 2024 |
| 451. Successful Gene Transfer in Passively Immunized Mice With Immunologically-Inert AAVrh. 10 Vectors R Selot, B Balakrishnan, S Cheemadan, S Govindarajan, R Gadkari, ... Molecular Therapy 23, S179, 2015 | | 2015 |
| Targeted Bio-Engineering of Adeno Associated Virus Serotype rh. 10 Capsid Improves Its Gene Delivery In Vitro and In Vivo R Selot, N Gabriel, M Kumari, GR Jayandharan MOLECULAR THERAPY 21, S211-S212, 2013 | | 2013 |
| Acknowledgements 1 GRJ is supported by research grants from Department of Science of Technology (DST), 2 R Selot, S Marepally, PK Vemula, GR Jayandharan, GR Jayandharan Gene expression 17 (18), 19, 0 | | |
